Pathogens exert physical force to avoid ingestion within phagocytes
A previously unknown process by which pathogens breach immune defences offers promise for treating infectious diseases.
List view / Grid view
A previously unknown process by which pathogens breach immune defences offers promise for treating infectious diseases.
The development of a treatment that prevents and treats Chlamydia uses nanotechnology, and could change the way the disease is treated...
Human induced pluripotent stem cell derived macrophages (iPSDMs) provide a cell-based model system to study chlamydia infection in the laboratory. Amy Yeung from Wellcome Trust Sanger Institute explains how she used this model in combination with CRISPR-Cas 9 technology to explore the potential of the two genes, IRF5 and IL10RA,…
Included in this Targets In-Depth Focus: Intracellular target validation in cellular systems; New drug targets identified to defend against chlamydia infections using CRISPR and stem cells; Novel solutions for tough targets with real bite...
Scientists have created an innovative technique for studying how chlamydia interacts with the human immune system...
20 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists have developed the first widely protective vaccine against chlamydia, a common STI that impacts 113 million people each year and can result in infertility...